Spyre Therapeutics
SYRE
SYRE
59 hedge funds and large institutions have $140M invested in Spyre Therapeutics in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $155M → $140M (-$15.2M)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
Holders
59
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.01M | |
| 2 | +$2.87M | |
| 3 | +$2.54M | |
| 4 |
BlackRock
New York
|
+$1.98M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.38M |
Top Sellers
| 1 | -$5.04M | |
| 2 | -$2.18M | |
| 3 | -$1.65M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.42M |
| 5 |
JP Morgan Chase
New York
|
-$711K |